This week’s blog is written by NIHR undergraduate intern, Abi Steward, who will be commencing an integrated Master’s programme at the University of Birmingham @UoB_SoP in September. Abi was supervised by Sam Finn and Helen Winmill, and the PICU Research Team. Seeing Beyond the Bedside: A Psychology Student’s Research Internship Journey on PICU In the […]Read More…
Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according to Dr. Jacob Sands.
Jake Messier uses TikTok to raise awareness about male breast cancer, advocate for inclusivity and foster community after his stage 4 diagnosis.
July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.
Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.
This week’s blog is written by NIHR undergraduate intern, Abi Steward, who will be commencing an integrated Master’s programme at the University of Birmingham @UoB_SoP…
This webinar delves into the unique challenges associated with bispecific antibodies. We’ll cover topics such as securing prior authorizations, navigating payer policies, optimizing vial selection…
Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.
The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical…
An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.
